Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2981 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Bioniche acquires Baxter’s Enlon product line

The acquired product line includes Enlon (edrophonium chloride injection, USP) 10mg/ml, 15ml vial, Enlon-Plus (edrophonium chloride, USP and atropine sulfate, USP) injection 5ml ampule and Enlon-Plus (edrophonium chloride,

P&G terminates collaboration agreement with ARYx

The agreement covers the late-stage development and commercialization of ATI-7505, a prokinetic agent in Phase II clinical trials for chronic constipation and functional dyspepsia. Under the terms of

USHIFU acquires Focus Surgery

This acquisition is expected to accelerate USHIFU’s ability to expand the Focus Surgery’s high-intensity focused ultrasound (HIFU) technology platform, as well as gain access to new markets, such

Peregrine wins $44.4 million DTRA contract

The initial contract was awarded through the transformational medical technologies initiative of the US Department of Defense’s Defense Threat Reduction Agency (DTRA). Under the terms of the contact,

Applera changes name to Applied Biosystems

Celera has become an independent publicly traded company that holds the businesses, assets and liabilities previously attributed to the Celera Group. With the separation of Celera, Applera will